Cao Angela A, Brown Meghan M, Lee Michael S, Rashidi Anita M, Rashidi Vania
Department of Ophthalmology and Visual Neurosciences, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, Minnesota, USA.
Neuroophthalmology. 2025 Feb 18;49(3):224-231. doi: 10.1080/01658107.2024.2424209. eCollection 2025.
We report a case of a 19-year-old Somali American woman who presented with 6 months of progressive bilateral vision changes and ocular discharge, with systemic symptoms including angular cheilitis and dermatitis. The patient was evaluated with comprehensive ophthalmic examination, optical coherence tomography, corticospinal magnetic resonance imaging, and fundus imaging. Comprehensive ophthalmic examination revealed bilateral optic neuropathy. Laboratory testing showed a biotinidase level of <0.1 (normal, 5.5-10 nmol/min/ml). The patient was treated with oral biotin supplementation with improvement in her visual function. Furthermore, a review of the literature of reported cases of biotinidase deficiency optic neuropathy published between June 1987 and February 2024 revealed 40 cases. This entity presents more commonly in males (63%) ( = 27), with an average age of 11.7 ± 12.0 years ( = 35). Patients experienced symptoms for an average of 4.3 ± 8.3 years before they were correctly diagnosed ( = 25). Individuals had an average BCVA of 20/300 in the right eye and 20/250 in the left eye ( = 15) at the time of presentation. Additionally, 38.9% of patients had color vision deficits ( = 18), and 100% of patients had visual field deficits ( = 19). All patients were treated with oral biotin supplementation ( = 25). This case and review of the literature underscore that biotinidase deficiency should be considered in patients with bilateral and progressive optic neuropathy among young adults. Early diagnosis is important as biotin supplementation may halt and/or reverse the disease process.
我们报告了一例19岁的索马里裔美国女性病例,该患者出现进行性双侧视力改变和眼部分泌物6个月,并伴有包括口角炎和皮炎在内的全身症状。对该患者进行了全面眼科检查、光学相干断层扫描、皮质脊髓磁共振成像和眼底成像。全面眼科检查显示双侧视神经病变。实验室检查显示生物素酶水平<0.1(正常范围为5.5 - 10 nmol/min/ml)。患者接受口服生物素补充治疗后视觉功能有所改善。此外,对1987年6月至2024年2月间发表的生物素酶缺乏性视神经病变报告病例的文献回顾发现了40例。该疾病在男性中更为常见(63%)(n = 27),平均年龄为11.7±12.0岁(n = 35)。患者在正确诊断前平均出现症状4.3±8.3年(n = 25)。患者就诊时右眼平均最佳矫正视力为20/300,左眼为20/250(n = 15)。此外,38.9%的患者存在色觉缺陷(n = 18),100%的患者存在视野缺损(n = 19)。所有患者均接受口服生物素补充治疗(n = 25)。该病例及文献回顾强调,对于年轻成人中出现双侧进行性视神经病变的患者应考虑生物素酶缺乏症。早期诊断很重要,因为补充生物素可能会阻止和/或逆转疾病进程。